Biotech • Diagnostics • Medtech
Scientific development for milestones that have to go right.
CogMind Consulting helps early-stage life-science companies translate scientific, regulatory, and funding requirements into executable development plans, defensible evidence, and traceable documentation.
Services
Support where scientific rigor meets execution
Small life-science teams rarely need another layer of generic advice. They need experienced help translating requirements into experiments, documentation, decisions, and progress.
Validation & Evidence Strategy
Design validation programs that generate evidence appropriate to the intended scientific, clinical, and regulatory use.
Capabilities
- Analytical and bioanalytical validation planning
- Validation protocol development
- Acceptance-criteria development
- Requirements and traceability
- Study design
- Data-review frameworks
- Validation-report preparation
- Gap assessments
- Vendor and CRO oversight
Scientific Development & Program Leadership
Bring structure to multidisciplinary R&D programs without hiring a full-time senior development leader.
Capabilities
- Development roadmaps
- Experimental strategy
- Technical project leadership
- Risk registers
- Milestone planning
- Decision documentation
- Cross-functional coordination
- CRO and vendor management
- Fractional scientific-development leadership
SBIR/STTR & Non-Dilutive Development Strategy
Build funding proposals around technically credible milestones — and create development programs that remain useful after the award.
Capabilities
- Opportunity assessment
- Scientific strategy
- Specific Aims development
- Experimental plans
- Milestone design
- Commercialization-development alignment
- Budget justification support
- Proposal coordination
- Post-award technical execution
Diagnostics, Devices & Translational R&D
Support early technology development from feasibility through verification, validation, and preparation for scale.
Capabilities
- Diagnostic assay development
- Medical-device concept development
- Prototype planning
- Design input and requirements development
- Verification and validation strategy
- Design-for-manufacturing coordination
- Laboratory and process scale-up
- Preclinical experimental planning
- Technical documentation
Engagements may include focused assessments, defined technical projects, or ongoing fractional scientific-development support. Tell us what you are working toward.
A defined starting point
Not sure where the development gaps are? Start with a readiness review.
Scientific Development & Validation Readiness Assessment
A focused review for teams approaching an expensive study, validation, regulatory interaction, or development milestone.
Scoped to the technology, evidence available, and upcoming milestone.
Typical review areas
- Intended use and development objectives
- Existing evidence
- Experimental design
- Validation strategy
- Regulatory expectations
- Acceptance criteria
- Technical risk
- CRO and vendor scope
- Documentation and traceability
- Near-term decision points
Typical outputs
- Structured gap assessment
- Prioritized risk register
- Evidence and requirements matrix
- Recommended development roadmap
- Executive readout
Who we help
Built for small teams doing difficult science
These teams usually have strong technology, a short bench, and a milestone that arrives sooner than the infrastructure needed to support it.
Biotech Startups
Especially teams preparing for translational, clinical, or regulatory milestones.
Diagnostics & Biomarkers
Assay development, analytical validation, clinical bioanalysis, and evidence planning.
Medical Technology
Development planning, V&V strategy, technical documentation, and multidisciplinary execution.
University Spinouts
Turning academic evidence into fundable, testable development programs.
SBIR-Funded Companies
Aligning non-dilutive funding with useful technical milestones.
Accelerators & Investors
Scientific diligence, technical mentoring, and development support for portfolio companies.
We also consider selected projects with nonprofits, established life-science companies, CROs, and professional-services firms requiring specialized scientific expertise.
When to call
Call before the expensive part goes wrong.
The earlier these problems are identified, the less expensive they usually are to solve.
Discuss a Project- You are about to run a validation study that would be difficult or expensive to repeat.
- Your assay needs to support a clinical trial.
- You have an upcoming FDA interaction and need the technical questions framed correctly.
- Your CRO has proposed a plan, but you need an independent scientific review.
- Your startup received funding and now needs an executable development program.
- Your technical team, clinicians, vendors, and leadership are not fully aligned.
- Your documentation does not clearly connect requirements, experiments, acceptance criteria, and conclusions.
- You need senior scientific-development leadership but are not ready for another full-time executive.
- You are pursuing SBIR/STTR funding and want the proposal to support the actual development path.
Approach
Rigor without unnecessary bureaucracy
The goal is not to create documentation for its own sake. The goal is to make technical decisions explicit, evidence traceable, and execution easier.
The line we keep intact
- Requirement
- Risk
- Experiment
- Evidence
- Decision
01
Define
Clarify the intended use, milestone, technical question, constraints, and definition of success.
02
Map
Translate scientific, regulatory, clinical, and business requirements into an evidence plan.
03
De-risk
Identify assumptions, failure modes, missing evidence, and decisions that should be resolved before expensive execution.
04
Execute
Develop protocols, coordinate collaborators, monitor progress, review data, and maintain alignment across the program.
05
Document
Create clear, traceable technical records that connect requirements, methods, results, deviations, conclusions, and next decisions.
Why CogMind
Technical depth without the big-consultancy handoff
Senior attention
Clients work directly with experienced scientific leadership rather than being sold by one team and handed to another.
Strategy connected to execution
Recommendations are designed around experiments, deliverables, budgets, timelines, and real-world constraints.
Cross-disciplinary translation
Comfort working among scientists, physicians, engineers, CROs, executives, and regulatory specialists.
Independent of the bench
We do not operate a laboratory or compete for the execution work, which keeps advice on study design, vendor selection, and data interpretation free of that conflict.
Documentation as infrastructure
Requirements, decisions, evidence, and risk are organized so development remains traceable as the organization grows.
Built for early-stage companies
Practical support appropriate to small teams that need rigor without unnecessary overhead.
Experience
Experience across the development lifecycle
Selected work from the principal scientist's career across academic, startup, and diagnostic-development settings.
Non-Dilutive Funding
More than $2 million in NIH SBIR funding secured across Phase I and Phase II diagnostic-development programs.
Clinical Bioanalysis
Method-validation planning and technical documentation supporting bioanalytical assays used in gene-therapy clinical development.
Diagnostics
Experience spanning early assay R&D, test-strip development, CLSI-oriented verification and validation, instrument development, and process scale-up.
Translational R&D
Preclinical research spanning controlled drug delivery, biomaterials, and medical-device applications.
Scientific Communication
Eight peer-reviewed publications, scientific presentations, technical reports, protocols, grant applications, and multidisciplinary development documentation.
Selected work
Selected development experience
Anonymized summaries of programs led or supported by our principal scientist. Client identities and proprietary details are withheld.
01
Building a funded diagnostic-development program
- Challenge
- An emerging diagnostic platform required technically credible development programs capable of supporting successive NIH SBIR applications.
- Contribution
- Scientific strategy, experimental planning, validation strategy, technical writing, milestone development, budget justification, and cross-functional program coordination.
- Outcome
- More than $2 million in Phase I and Phase II NIH SBIR funding secured across multiple disease-target programs.
02
Preparing a bioanalytical method for clinical use
- Challenge
- A bioanalytical assay supporting a gene-therapy clinical trial required a structured validation program and defensible technical documentation.
- Contribution
- Validation-plan development, regulatory-guidance alignment, acceptance-criteria review, laboratory coordination, data-review strategy, and technical documentation.
- Outcome
- A structured method-validation framework designed to support reliable clinical bioanalysis and regulatory review.
03
Translating diagnostic R&D toward scalable execution
- Challenge
- An early diagnostic technology required progression from laboratory experimentation toward controlled manufacturing and V&V activities.
- Contribution
- Assay development, test-strip research, meter-related development support, verification and validation planning, laboratory buildout, membrane-coating process implementation, and multidisciplinary coordination.
- Outcome
- Established technical capabilities and development infrastructure supporting subsequent diagnostic programs.
About
Scientific leadership that can work across the room
CogMind Consulting is led by a Ph.D. biomedical engineer with experience spanning translational research, diagnostic development, medical technology, regulated bioanalysis, non-dilutive funding, and multidisciplinary scientific program leadership.
His work has included NIH-funded diagnostic programs, clinical bioanalytical method validation, preclinical drug-delivery research, device and assay development, laboratory scale-up, and technical strategy across academic and startup environments.
The common thread is translating complicated scientific problems into structured programs that scientists, clinicians, engineers, executives, and external partners can execute together.
Projects can incorporate additional scientific, engineering, statistical, regulatory, and technical expertise through trusted collaborators when required.
Insights
Practical guidance for difficult development decisions
Short, specific writing on the decisions early-stage teams face before a study, submission, or regulatory conversation.
Why I’m Building CogMind Consulting
Helping early-stage life-science teams navigate the technical milestones they cannot afford to get wrong.
Read the articleAn SBIR Award Is a Development Program, Not Just a Grant
How to design milestones that advance the product rather than merely satisfy an application.
Read the articleBefore You Send the Validation Protocol to the Lab
Questions early-stage companies should resolve before committing samples, budget, and time to a high-consequence study.
Read the article
Contact
Have a milestone you cannot afford to get wrong?
Tell us what is approaching — a validation, study, FDA interaction, SBIR submission, technical decision, or development bottleneck. We can quickly determine whether CogMind is the right fit and what type of support would be useful.
Initial conversations are confidential and focused on determining fit, scope, and the most important technical risks.
Remote engagements nationwide • Onsite support available in the Philadelphia and Mid-Atlantic region